Last reviewed · How we verify

NCT06233188

Effect of Customized Lateral Nasal Wall Osteotomy on the Pterygomaxillary Separation During le Fort I Down-fracture

Completed NA Last updated 31 January 2024
What this trial tests

NA trial testing orthogantic surgery in Malocclusion in 43 participants. Completed in 5 December 2023.

Timeline
3 May 2023
Primary endpoint
15 October 2023
5 December 2023

Quick facts

Lead sponsorBezmialem Vakif University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment43
Start date3 May 2023
Primary completion15 October 2023
Estimated completion5 December 2023
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Bezmialem Vakif University

Who can join

18 and older, any sex, with Malocclusion or Open Bite. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this clinical trial is to show the effect of patient specific lateral nasal wall osteotomy to the pterygomaxillary separation during Le Fort I down-fracture. Participants will be divided into two treatment groups. In study group, surgery planned according to the patients' indivudial anatomy and in the conventional group, surgery planned according to mean anatomical datas. Researchers will compare patient specific lateral nasal wall osteotomy to see if it affects the pterygomaxillary junction seperation during le fort I downfracture.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. What is the impact of lateral nasal wall osteotomy depth on pterygomaxillary separation during a Le Fort I downfracture?
    Pergel T, Akkoyun EF, Kasarcioglu G, Dolanmaz D. · · 2025 · cited 1× · PMID 39864080 · DOI 10.4317/medoral.26939

Verify or expand the search:

Other recruiting trials for Malocclusion

Currently open trials in the same condition.

Other Bezmialem Vakif University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06233188.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing